NDC 72384-753

Stendra

Avanafil

Stendra is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Metuchen Pharmaceuticals, Llc. The primary component is Avanafil.

• Product ID: 72384-753_02c03667-4518-4b43-ae10-f915132a0224
• NDC: 72384-753
• Product Type: Human Prescription Drug
• Proprietary Name: Stendra
• Generic Name: Avanafil
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2013-12-27
• Marketing Category: NDA / NDA
• Application Number: NDA202276
• Labeler Name: Metuchen Pharmaceuticals, LLC
• Substance Name: AVANAFIL
• Active Ingredient Strength: 200 mg/1
• Pharm Classes: Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72384-753-30

30 TABLET in 1 BOTTLE (72384-753-30)

• Marketing Start Date: 2013-12-27
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Stendra" or generic name "Avanafil"

NDC	Brand Name	Generic Name
62541-501	STENDRA	Avanafil
62541-502	STENDRA	Avanafil
62541-503	STENDRA	Avanafil
72384-751	Stendra	avanafil
72384-752	Stendra	avanafil
72384-753	Stendra	avanafil
76299-320	Stendra	avanafil
76299-321	Stendra	avanafil
76299-322	Stendra	avanafil